2023
DOI: 10.1007/s10565-023-09835-4
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity

Silin Liu,
Chongkai Fang,
Chong Zhong
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 125 publications
0
1
0
Order By: Relevance
“… HiPSC-derived hepatocytes [ 51 , 52 ]. HiPSC-derived cardiac myocytes [ 53 , 54 ]. HiPSC-Derived gastric cells [ 55 ].…”
Section: Physiological Relevance Of 3d Cell Cultures To the Ecmmentioning
confidence: 99%
“… HiPSC-derived hepatocytes [ 51 , 52 ]. HiPSC-derived cardiac myocytes [ 53 , 54 ]. HiPSC-Derived gastric cells [ 55 ].…”
Section: Physiological Relevance Of 3d Cell Cultures To the Ecmmentioning
confidence: 99%
“…Another study accurately characterizes cardiotoxic damage caused by the anticancer drug doxorubicin through self-assembled cardiac organoids [ 164 ]. It has recently been found that hiPSC-CMs can be used to simulate antitumor drug-induced cardiotoxicity in vitro [ 165 ], which may provide more recommendations for future use of antitumor drugs. For example, the chemotherapy drug mitoxantrone can cause arrhythmias, and studies in cardiac organoids have found that co-administration of metformin can partially reverse this effect [ 166 ].…”
Section: Application Of Cardiovascular Organoidsmentioning
confidence: 99%